New Delhi -India had a largely inconsistent growth in clinical research related to cancer since 2001, despite a strong economic growth, suggesting that development could be a contributing factor towards disparities among the low and middle-income countries in cancer research, according to a new study.
Cancer cases and deaths are projected to surge in the coming decades with low and middle-income countries expected to bear a disproportionate burden.
However, researchers, including those from the the Latin American Cooperative Oncology Group, said that clinical trials of cancer are disproportionally concentrated in high-income countries, even as previous evidence suggests an increase in trials among low and middle-income nations.
The study, published in the journal ‘CANCER’, looked at di